WO2001041789A1 - Medicament contre les rhumatismes contenant un derive tetrapeptidique en tant qu'ingredient actif - Google Patents
Medicament contre les rhumatismes contenant un derive tetrapeptidique en tant qu'ingredient actif Download PDFInfo
- Publication number
- WO2001041789A1 WO2001041789A1 PCT/JP2000/008614 JP0008614W WO0141789A1 WO 2001041789 A1 WO2001041789 A1 WO 2001041789A1 JP 0008614 W JP0008614 W JP 0008614W WO 0141789 A1 WO0141789 A1 WO 0141789A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- rheumatism
- therapeutic agent
- active ingredient
- atom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU17307/01A AU1730701A (en) | 1999-12-07 | 2000-12-06 | Rheumatism remedy containing tetrapeptide derivative as active ingredient |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34700399 | 1999-12-07 | ||
JP11/347003 | 1999-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001041789A1 true WO2001041789A1 (fr) | 2001-06-14 |
Family
ID=18387273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/008614 WO2001041789A1 (fr) | 1999-12-07 | 2000-12-06 | Medicament contre les rhumatismes contenant un derive tetrapeptidique en tant qu'ingredient actif |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1730701A (fr) |
WO (1) | WO2001041789A1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0598129A1 (fr) * | 1991-08-09 | 1994-05-25 | Teikoku Hormone Mfg. Co., Ltd. | Nouveau derive de tetrapeptide |
JPH111434A (ja) * | 1997-06-12 | 1999-01-06 | Rikagaku Kenkyusho | チューブリン重合阻害剤、細胞周期阻害剤及び抗腫瘍剤 |
WO1999017792A1 (fr) * | 1997-10-06 | 1999-04-15 | Basf Aktiengesellschaft | Methodes et compositions de traitement de la polyarthrite rhumatoide |
-
2000
- 2000-12-06 AU AU17307/01A patent/AU1730701A/en not_active Abandoned
- 2000-12-06 WO PCT/JP2000/008614 patent/WO2001041789A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0598129A1 (fr) * | 1991-08-09 | 1994-05-25 | Teikoku Hormone Mfg. Co., Ltd. | Nouveau derive de tetrapeptide |
JPH111434A (ja) * | 1997-06-12 | 1999-01-06 | Rikagaku Kenkyusho | チューブリン重合阻害剤、細胞周期阻害剤及び抗腫瘍剤 |
WO1999017792A1 (fr) * | 1997-10-06 | 1999-04-15 | Basf Aktiengesellschaft | Methodes et compositions de traitement de la polyarthrite rhumatoide |
Non-Patent Citations (1)
Title |
---|
BAI RUOLI ET AL.: "Dolastatin 15, a potent antimitotic depsipeptide derived from dolabella auricuria", BIOCHEMICAL PHARMACOLOGY, vol. 43, no. 12, 1992, pages 2637 - 2645, XP002937861 * |
Also Published As
Publication number | Publication date |
---|---|
AU1730701A (en) | 2001-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS60248618A (ja) | ジペプチドを含有する潰瘍治療剤 | |
AU2004233587A1 (en) | Use of a topical medicament comprising Riluzole | |
JPH0920659A (ja) | 炎症性腹部疾患のためのカッパ−アヘン製剤作働薬 | |
JP2000514415A (ja) | ソマトスタチン類似体およびラパマイシンの配合 | |
WO2003006019A1 (fr) | Composition medicinale destinee au traitement de la cystite interstitielle | |
JP2009539996A (ja) | 腎機能障害を持つ個体における利尿改善方法 | |
EP3883918B1 (fr) | Inhibiteurs de rip1 | |
EP0412940B1 (fr) | Dérivés de l'hydantoine ou de l'imidazolidinetrione pour la prévention ou le traitement de l'insuffisance rénale | |
EP0674904B1 (fr) | Utilisation des composés de diester d'acide phosphorique pour la suppression des métastases du cancer du foie | |
EP1941876A1 (fr) | Derivés du mononitrite de l'isosorbide destinées au traitement de l'inflammation et l'hypertension oculaire | |
MXPA06011823A (es) | Terapia de combinacion, que comprende un antagonista del receptor de la adenosina a1 y un inhibidor de la aldosterona. | |
EP0534907B1 (fr) | Utilisation de dérivées de furanone pour prevenir ou traiter des maladies d'autoimmunité | |
WO2024022468A1 (fr) | Utilisation de rhamnose dans la préparation d'un médicament pour le traitement ou la prévention de maladies neurodégénératives, composition pharmaceutique et son utilisation | |
RU2341261C2 (ru) | Композиции, содержащие эпотилоны, и их применение для лечения карциноидного синдрома | |
JPH0352815A (ja) | 血管内血液凝固症候群の治療剤 | |
KR100851938B1 (ko) | 방광 질환의 치료를 위한 카프-오피에이트 작용제 | |
JPH0269417A (ja) | 精神分裂病治療用組成物 | |
WO2001041789A1 (fr) | Medicament contre les rhumatismes contenant un derive tetrapeptidique en tant qu'ingredient actif | |
EP0650723A2 (fr) | Nouvelles utilisations pharmaceutiques des dérivés de la forskoline | |
AU2022260191A1 (en) | Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance | |
AU743941B2 (en) | Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy | |
JPH0352816A (ja) | 腎炎の治療剤 | |
KR100609256B1 (ko) | 다발성 골수종의 골 병변 치료용 의약 조성물 | |
US4298611A (en) | Process for reducing blood pressure in animals | |
JP3450399B2 (ja) | 血管新生阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |